A Combination of flk1-Based DNA Vaccine and an Immunomodulatory Gene (IL-12) in the Treatment of Murine Cancer

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cancer Biotherapy and Radiopharmaceuticals

• Publication date

  2004-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/cbr.2004.19.649PMID 15650458
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intratumoral Administration of Recombinant Human Interleukin 12 in Head and Neck Squamous Cell Carcinoma Patients Elicits a T-Helper 1 Profile in the Locoregional Lymph Nodes

  2004cited by this paper
• Vaccination with minigenes encoding for novel 'self' antigens are effective in DNA-vaccination against neuroblastoma.

  2003cited by this paper
• Active Immunization Against the Vascular Endothelial Growth Factor Receptor flk1 Inhibits Tumor Angiogenesis and Metastasis

  2002cited by this paper
• A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth

  2002cited by this paper
• Intratumoral injection of interleukin-12 plasmid DNA, either naked or in complex with cationic lipid, results in similar tumor regression in a murine model.

  2002cited by this paper
• Can mosaic tumor vessels facilitate molecular diagnosis of cancer?

  2001cited by this paper
• Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction

  2001cited by this paper
• Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine

  2000cited by this paper
• Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development.

  1999cited by this paper
• The Toxicology of Interleukin-12: A Review

  1999cited by this paper
• Interleukin-12 Gene Transfer Results in CD8-Dependent Regression of Murine CT26 Liver Tumors

  1999cited by this paper
• Gene gun-mediated IL-12 gene therapy induces antitumor effects in the absence of toxicity: a direct comparison with systemic IL-12 protein therapy.

  1999cited by this paper
• Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumors

  1998cited by this paper
• Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis.

  1998cited by this paper
• Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis.

  1998cited by this paper
• Amount of interleukin 12 available at the tumor site is critical for tumor regression.

  1996cited by this paper
• Patterns and Emerging Mechanisms Review of the Angiogenic Switch during Tumorigenesis

  1996cited by this paper
• Direct Intratumoral Injection of an Adenovirus Expressing Interleukin-12 Induces Regression and Long-Lasting Immunity That Is Associated with Highly Localized Expression of Interleukin-12

  1996cited by this paper
• Construction of a Double Recombinant Adenovirus Vector Expressing a Heterodimeric Cytokine: In Vitro and In Vivo Production of Biologically Active Interleukin-12

  1996cited by this paper
• Sciencescope.

  1995cited by this paper
• Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo

  1995cited by this paper
• Cancer Trial of Interleukin-12 Halted

  1995cited by this paper
• Progressive growth in immunodeficient mice and host cell recruitment by mouse endothelial cells transformed by polyoma middle-sized T antigen: implications for the pathogenesis of opportunistic vascular tumors.

  1994cited by this paper
• Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-gamma in vivo.

  1994cited by this paper
• Molecular Mechanisms of Developmental and Tumor Angiogenesis

  1994cited by this paper
• A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit.

  1991cited by this paper

• Intratumoral Injection of mRNA Encoding Survivin in Combination with STAT3 Inhibitor Stattic Enhances Antitumor Effects.

  2024cites this paper
• Immunocompetent murine models for the study of glioblastoma immunotherapy

  2014cites this paper
• Therapeutic effect of recombinant plasmid-encoded human interleukin-12 in tumor-bearing mice.

  2012cites this paper
• AntiTumor Mechanism of Recombinant Murine Interleukin-12 Vaccine

  2010cites this paper
• Synergistic antitumor effects of 131I-LC-1 IgM and IL-12 vaccine on Lewis lung carcinoma.

  2010cites this paper
• Salmonella Vaccines for Animals and Birds and Their Future Perspective

  2009influential citation
• Inhibition Growth and Metastasis of Melanoma by 4-1BBL Expressed in Normal Tissue Cells by Regulating the Function of Immune Cells

  2009cites this paper
• A safety and efficacy study of local delivery of interleukin-12 transgene by PPC polymer in a model of experimental glioma

  2008cites this paper
• Immunotherapy of Angiogenesis with DNA Vaccines

  2008cites this paper
• Non-viral delivery of interleukin-2 and soluble Flk-1 inhibits metastatic and primary tumor growth in renal cell carcinoma

  2007cites this paper
• Evaluation of a xenogeneic VEGF vaccine in dogs with soft tissue sarcoma

  2007cites this paper
• Mannosylated chitosan nanoparticle–based cytokine gene therapy suppressed cancer growth in BALB/c mice bearing CT-26 carcinoma cells

  2006cites this paper
• Lenalidomide: an immunomodulatory drug.

  2005cites this paper